Saturday, September 21, 2019

New medication to prevent CMV for organ transplant recipient?

Let’s come back to Letermovir. It has also obtained the status of Orphan Drug in the European Union (EU). That status is reserved for drugs used to treat rare disease that affects a minority of the population. The drug company is given tax breaks and marketing exclusivity for 7 years in the US and 10 years in EU. This is an incentive that was created by the governments to incite drug companies to develop medicine against rare disease. CMV is known to affect less than 200,000 people in the US, most of them being organ transplant patients.

Valcyte has been on the market for 10 years and Letermovir seems to be the most serious alternative to date. With clinical trials underway we should know soon if this drug has a bright future in helping organ transplant recipients.

Pierre Luc Charland
Pierre Luc Charland
Aside from being a very experienced transplant coordinator in the Houston area, Pierre is also an amazing content creator for our properties. Pierre plays a key role in driving our mission and offering expert insight to the ever evolving world of transplantation.

Facebook Comments

Regular Comments


Please enter your comment!
Please enter your name here


Must Read

Five Shocking Facts about Transplant Medications

According to UNOS, 19,513 transplants were performed between January and June 2019. While their diagnoses and organ needs differ, all transplant recipients share one...

Trump’s New Kidney Dialysis Directive To Save Lives And Money

President Donald Trump has signed an executive order aimed at reducing the cost of kidney treatment by increasing the availability of kidney transplants. According to...

Disparity Persists In Kidney Transplantation for Hispanics and African Americans

For two decades now, there has been a campaign to increase the number of Hispanic and black patients receiving kidney transplants from related and...

It’s Time to Eliminate the Monopolies in Organ Donation

We have always been told that competition makes people or businesses better, right??  It pushes us to work a little harder which at the...

Ever Think About Donating Part of Your Liver? On Average Over 400 Americans Do Every Year

The Ed Henry story is helping promote living donation for liver transplantation. Ed Henry is a journalist for Fox News and he decided to donate...